Biogen Inc. (NASDAQ:BIIB) ranks among the most undervalued NASDAQ stocks to buy now. On September 18, Biogen Inc. (NASDAQ:BIIB) announced that it had finalized a deal to acquire Alcyone Therapeutics for an initial cash payment of $85 million and milestone payments. The acquisition focuses on the ThecaFlex DRx, an implantable subcutaneous port and catheter device that is being researched for antisense oligonucleotide (ASO) intrathecal delivery. The system is intended to give patients with neurological ill ...